CCL3 and gastric cancer: In a study investigating gastric cancer [82], researchers observed that blocking the activator receptor of MCs significantly inhibited the enrichment of MC cells and downregulated the chemokines CCL2/CCL3 in macrophages, resulting in a reduction in gastric cancer cell levels.